🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A prospective pilot trial was proposed to patients with DLBCL, with IH or h...
Status
Completed
Location
University Hospital
Start Date
2002-04
Trial ID
NCT00965289
Treatments Being Tested
One of the possible options for the treatment of MS at present is a high-do...
Status
Recruiting
Location
First Pavlov State Medical University of St. Petersburg
Start Date
2020-10-01
Trial ID
NCT05832515
Treatments Being Tested
This study will evaluate the efficacy, safety and patient reported outcomes...
Status
Unknown
Location
Multiple Locations
Start Date
2020-09-01
Trial ID
NCT04516655
Treatments Being Tested
This is a 12-month phase 2, prospective, open label study to evaluate the e...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00446251
Treatments Being Tested
Demyelinating Diseases of the Central Nervous System Registry for Patients ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-06-20
Trial ID
NCT05415579
Treatments Being Tested
The primary objective of this trial is to improve the overall survival rate...
Status
Recruiting
Location
Subang Jaya Medical Centre
Start Date
2020-03-04
Trial ID
NCT06336395
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Unknown
Location
Medizinische Klinik, Klinikum Augsburg
Start Date
2005-06
Trial ID
NCT00397800
Treatments Being Tested
The goal of this clinical research study is to learn if it is safe and feas...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-07-13
Trial ID
NCT01471067
This is a phase 3, multicenter, randomized, double-blind, placebo-controlle...
Status
Active Not Recruiting
Location
MorphoSys Research Site
Start Date
2021-05-11
Trial ID
NCT04824092
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-08
Trial ID
NCT01421173